Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;144(16):3354-3364.
doi: 10.1017/S0950268816001801. Epub 2016 Aug 11.

Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011

J Pinchoff  1 , O C Tran  1 , L Chen  1 , K Bornschlegel  1 , A Drobnik  1 , L Kersanske  1 , J Fuld  1
Affiliations

Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011

J Pinchoff et al. Epidemiol Infect. 2016 Dec.

Abstract

High rates of immigration from endemic countries contribute to the high chronic hepatitis B (HBV) prevalence in New York City (NYC) compared to the United States overall, i.e. about 1 million individuals. We describe the impact of HBV infection on mortality and specific causes of death in NYC. We matched surveillance and vital statistics mortality data collected from 2000 to 2011 by the New York City Department of Health and Mental Hygiene (DOHMH) and analysed demographics and premature deaths (i.e. whether death occurred at <65 years) in persons with and without chronic HBV or HIV infection (excluding those with hepatitis C). From 2000 to 2011, a total of 588 346 adults died in NYC. Of all decedents, 568 753 (97%) had no report of HIV or HBV, and 4346 (0·7%) had an HBV report. Of HBV-infected decedents, 1074 (25%) were HIV co-infected. Fifty-five percent of HBV mono-infected and 95% of HBV/HIV co-infected decedents died prematurely. HBV disproportionately impacts two subgroups: Chinese immigrants and HIV-infected individuals. These two subgroups are geographically clustered in different neighbourhoods of NYC. Tailoring prevention and treatment messages to each group is necessary to reduce the overall burden of HBV in NYC.

Keywords: HIV/AIDS; Hepatitis B; mortality; surveillance.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Proportion of deaths that were not premature, premature (50–64 years) or very premature (<50 years) in New York City, stratified by report of HBV, 2000–2011. *Statistical significance (P < 0·05) when compared to decedents with neither infection.
Fig. 2.
Fig. 2.
(a) Average age-standardized mortality rate in HBV mono-infected persons/100 000 from 2000 to 2011, (b) percentage Chinese-born in 2010, (c) average age-standardized mortality rate in HBV/HIV co-infected persons per 100 000 from 2000–2011, and (d) poverty category per modified ZCTA in 2010, New York City. * Locator Map [Department of Epidemiology Services, New York City Department of Health. NYC Borough Map (https://www1.nyc.gov/assets/doh/downloads/pdf/epi/NYC_Borough_Map.pdf)].
See this image and copyright information in PMC

References

    1. Maclachlan J, Cowie B. Hepatitis B virus epidemiology. Cold Spring Harbor Perspectives in Medicine 2015; 5: a021410. - PMC - PubMed
    1. NYC DOHMH. Hepatitis B and C surveillance report: New York City 2013. New York, NY: New York City Department of Health and Mental Hygiene, Division of Disease Control, Bureau of Communicable Diseases, 2015.
    1. WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva, Switzerland, 2015. - PubMed
    1. CDC. Surveillance of viral hepatitis – United States, 2013. United States: Centers for Disease Control and Prevention, Hepatitis DoV, 20 July 2013, 2015 (http://www.cdc.gov/hepatitis/statistics/2013surveillance/pdfs/2013hepsur...).
    1. Stasi C, et al. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. Journal of Infection and Public Health 2016; 9: 389–395. - PubMed